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Opinion TRENDS in Parasitology Vol.23 No.2Leishmania are obligate intracellular parasites that
invade and survive within host macrophages and can
result in visceral leishmaniasis, a major public health
problem worldwide. The entry of intracellular parasites,
in general, involves interaction with the plasma mem-
brane of host cells. Cholesterol in host cell membranes
was recently shown to be necessary for binding and
internalization of Leishmania and for the efficient pre-
sentation of leishmanial antigens in infected macro-
phages. This article describes the need to explore
cyclodextrin-based compounds, which modulate host
membrane cholesterol levels, as a possible therapeutic
strategy against leishmaniasis in addition to other
intracellular parasites.
Role of cholesterol in membrane function and
organization
Cholesterol is an essential component of eukaryotic
membranes and has a crucial role in membrane organiza-
tion and function [1]. It is a predominantly hydrophobic
molecule (Figure 1), comprising of a near planar tetracyclic
fused sterol ring and a flexible isooctyl hydrocarbon tail.
The 3b-hydroxyl moiety gives cholesterol its amphiphilic
character causing it to orient in a bilayer with its long axis
perpendicular to the plane of the membrane. Cholesterol
has a variety of effects on the physical properties of mem-
branes [2]. When present at high concentrations in
model membranes, cholesterol induces the formation of
the liquid-ordered phase characterized by high packing
density and high mobility of membrane constituents [2].
Cholesterol is often found distributed non-randomly
in domains or pools in biological membranes [3,4]. For
example, caveolae represent morphologically distinct, cho-
lesterol-enriched structures in membranes of cells expres-
sing isoforms of the cholesterol-binding protein caveolin
[3]. The existence of a type of membrane domain enriched
in cholesterol (known as lipid rafts) has been proposed [5],
and is believed to represent the liquid-ordered phase
observed in model membranes [6]. Recent studies focused
on monitoring membrane dynamics and distribution of
membrane components, on a scale far lower than the
resolution of visible light microscopy, have indicated the
presence of small and dynamic lipid-based heterogeneities
under native conditions in cell membranes [7–9]. Choles-
terol is believed to be the principal constituent of theseCorresponding author: Chattopadhyay, A. (amit@ccmb.res.in).
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would disrupt their integrity [10], thereby leading to a loss
of putative functions mediated by these domains. Because
of their uniquemembrane environment and their potential
to organize receptors in the plane of the membrane,
domains such as lipid rafts and caveolae are believed to
represent portals for the entry of pathogens [11–13]. In
addition, cholesterol has been implicated in maintaining
the structure and function of integral membrane proteins
and receptors [14].
Role of cholesterol in infection by intracellular
pathogens
Several studies have indicated the crucial requirement of
cholesterol in host–pathogen interactions [reviewed in
Refs 11–13]. The ability to manipulate levels of cholesterol
in the membrane with a reasonable degree of specificity
has contributed to our understanding of its role in host–
pathogen interactions and subsequent infection. Choles-
terol content in the membrane can either be lowered by
using specific carriers, such as cyclodextrins (Figure 2), or
be made unavailable by using cholesterol-sequestering
agents (e.g. nystatin and filipin) [14]. Cyclodextrins, in
general, exhibit a broad specificity for extracting mem-
brane lipids. However, when used under low concentra-
tions, the oligomer with seven residues (b-cyclodextrin) of
methylated-glucose, methyl-b-cyclodextrin (MbCD), dis-
plays a relatively higher specificity for cholesterol and
other steroids compared with phospholipids [14,15]. Sev-
eral studies, using cultured cells as hosts, indicate that the
use of these compounds reduces infectivity of intracellular
pathogens, an effect that often correlates with the extent of
reduction in the membrane cholesterol content [11–13].
The role of cholesterol in pathogen infection can be cate-
gorized as a requirement either at the stage of pathogen
binding to cell surface receptors or during their internali-
zation into cells (or both) [13], or for their subsequent
survival within host cells [16]. Although a classification
of this kind provides mechanistic insights into the role of
cholesterol in pathogen infection, the situation could be a
combination of several factors that eventually manifests in
a reduction in infectivity of intracellular pathogens in cells
with reduced cholesterol content.
Cholesterol has been found to be required for the
internalization of several species of Mycobacteria into
macrophages [17,18]. Depletion or sequestration of choles-
terol in mouse macrophages results in a reduction in the
population of infected macrophages. Similar results haved. doi:10.1016/j.pt.2006.12.003
Figure 1. Structure and membrane orientation of cholesterol. (a) There are three structurally distinct regions of cholesterol (shaded boxes): the 3b-hydroxyl group, the rigid
sterol ring and the flexible alkyl chain. The 3b-hydroxyl moiety is the only polar group in cholesterol and serves to anchor cholesterol in the membrane. (b) Orientation o
cholesterol in relation to a phospholipid molecule in a lipid bilayer. The rigid and near-planar sterol ring contributes to the ordering effect of cholesterol in phospholipid
bilayers as a result of the restriction in motion imposed on it by adjacent phospholipid fatty acyl chains. The flexible alkyl chain extends into the hydrophobic core of the
membrane. Adapted and modified from Ref. [14].
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Escherichia coli [19] and caveolae-mediated endocytosis
of fimbriatedE. coli [20]. Cholesterol has also been found to
be required for phagocytosis of Brucella suis [21]. In the
case of Chlamydia trachomatis, cholesterol depletion
seems to inhibit phagocytosis of the parasite but not its
binding to cell surface receptors [22]. A cholesterol-depen-
dent entry process into host cells has been reported for
Listeria monocytogenes [23]. In this situation, depletion of
membrane cholesterol from the bacterium was found to
diminish binding of the pathogen to cellular receptors and
also to reduce endocytic uptake of the pathogen into host
cells. Interestingly, when Mycobacteria and B. suis are
coated with serum components, a process called opsoniza-
tion, the effect of cholesterol depletion or sequestration on
parasite entry is no longer observed [18,21].
In addition to bacterial pathogens, cholesterol depletion
has been found to inhibit the entry and sustained infection
of the protozoan malaria parasite Plasmodium falciparum
in erythrocytes [24]. The protozoan parasite Toxoplasma
gondii is particularly interesting in this context. The
growth and survival of T. gondii in the host depend on
efficient acquisition of cholesterol from host membranes by
a process involving the endocytosis of low-density lipopro-
tein (LDL) into host cells [16,25]. Direct lipid transfer from
host membranes to the parasite, mediated by specific
transporters in the parasite, has been proposed as a
mechanism for the acquisition of host cholesterol, thereby
representing strong candidates for therapeutic drugs
[16]. In contrast to T. gondii, the kinetoplast parasitewww.sciencedirect.comfTrypanosoma cruzi can synthesize specific sterols, such as
ergosterol, which are required for its survival and growth.
This specific requirement is met by the enzyme squalene
synthase, which catalyzes the first committed step in sterol
biosynthesis, not only in the parasite but also in humans.
Although similar to its mammalian homologue, in the
parasite this enzyme is emerging as a potential target for
antiparasite chemotherapy [26]. Interestingly, although
sterol synthesis inhibitors can induce growth arrest of T.
cruzi, perhaps as a result of a reduction in its endogenous
sterols, a concomitant increase in externally derived
cholesterol in the parasite is observed, implying the exis-
tence of an adaptive mechanism [26]. Nevertheless, this
compensatory mechanism does not contribute to the sur-
vival of the parasite possibly as a result of the inability of
cholesterol to fully mimic ergosterol, which is required for
the growth of the parasite. Taken together, these examples
indicate an intricate relationship that has evolved between
host cholesterol metabolism and infection by intracellular
parasites.
Leishmania infection
Leishmania cause leishmaniasis, which, under conditions
of overt visceral infection, is usually fatal if untreated
[27,28]. Leishmaniasis is now considered endemic in 88
countries in Africa, Asia, Europe, North America and
South America, with a total of 12 million people infected
worldwide and 350 million people at risk of infection
(WHO Factsheet, 2000: http://www.who.int/mediacentre/
factsheets / fs116 / en / index.html). The estimated annual
Figure 2. Role of cholesterol in Leishmania donovani infection. Cholesterol levels
in J774A.1 mouse macrophages were modulated using a specific carrier, methyl-b-
cyclodextrin (MbCD). (a) Chemical structure of a b-cyclodextrin (containing seven
glucose residues) molecule. Adapted and modified from Ref. [14]. Cyclodextrins
can solubilize a variety of hydrophobic compounds by trapping them in their inner
cavity. The specificity of this process depends on the structure of their inner cavity,
which can be modified by substitution of the hydroxyl groups (indicated as R in the
figure) in each glucose residue. The most commonly used cholesterol-depleting
agent is MbCD in which R is a methyl group. (b) The role of cholesterol in
Leishmania–macrophage interactions was monitored using radiolabeled binding
assays using L. donovani promastigotes on mouse macrophages depleted of
cholesterol using MbCD. Replenishment of cholesterol into cholesterol-depleted
macrophages using cholesterol complexed with MbCD demonstrated the
specificity of the role of cholesterol in host–pathogen interactions. Cholesterol
depletion with 10 mM MbCD results in a reduction in binding and uptake of
radiolabeled Leishmania into host macrophages. Replenishment of cholesterol
MbCD complex for varying time periods (5, 10 and 15 min). Figures 2b and c are
Opinion TRENDS in Parasitology Vol.23 No.2 51into MbCD-treated cells increasingly supports radiolabeled parasite-binding
ability. (c) The membrane cholesterol content in MbCD-treated macrophagesbefore and after treatment of cholesterol-depleted macrophages with cholesterol–
www.sciencedirect.comnumber of new cases of leishmaniasis is thought to be
two million [29] and of visceral leishmaniasis is
500 000 [27]. The current worldwide increase in leish-
maniasis to epidemic proportions, and the emergence of
visceral leishmaniasis as an important opportunistic
infection among people with human immunodeficiency
virus-1 (HIV-1) infection [29], have resulted in an urgent
requirement for treatment.
Leishmaniasis is transmitted by the female sand fly,
Phlebotomous spp., infected with Leishmania when taking
a bloodmeal from a host [30,31]. Once in the bloodstream,
promastigotes are efficiently phagocytosed by host macro-
phages. Entry of promastigotes into macrophages involves
recognition of specific ligands on the parasite cell surface
by macrophage receptors and subsequent internalization
of the promastigotes. Complement receptors CR1 and CR3
on the macrophage cell surface have major roles in the
entry processes. The interaction of the parasite with com-
plement receptors occurs through either a serum-depen-
dent or serum-independent pathway. In the presence of
serum, Leishmania promastigotes undergo opsonization,
resulting in their surface being covered with the C3bi
fragment of the host complement system. Because C3bi
binds to CR3 present on the macrophage cell surface,
opsonization enhances the entry of the parasite intomacro-
phages. The entry of Leishmania parasites can also occur
through a serum-independent process, which involves
either binding of the parasite surface protease gp63 to
CR3, or binding of the parasite lipophosphoglycan (LPG)
to the lectin-like site on CR3 and to CR1. The CR4, fibro-
nectin receptor, mannose receptor and the advanced gly-
cosylation end-product receptor have also been implicated
in the entry process [30]. Once inside the macrophage,
promastigotes undergo biochemical and metabolic
changes, thereby converting into the obligatory intracel-
lular amastigote form of the parasite. Amastigotes are
released from macrophages and can re-invade dendritic
cells and fibroblasts and other macrophages. The re-entry
of amastigotes into host cells is assumed to be mediated by
the Fc receptor for immunoglobulin G, in addition to CR3
and the mannose receptor [30]. Taken together, the redun-
dant nature (i.e. multiple receptor–ligand interactions) of
the parasite entry process makes it difficult to identify a
unique therapeutic target [28]. Host cells harboring amas-
tigotes subsequently mediate the spread of infection from
its initial site in the skin to the lymph nodes, in which the
parasites persist indefinitely.
Novel role of cholesterol in Leishmania infection
The requirement of host membrane cholesterol in the
binding and internalization of Leishmania donovani into
macrophage cells has recently been demonstrated using
complementary approaches [32,33]. Cholesterol depletion
from macrophages by cyclodextrins [32], or its sequestra-
tion by nystatin [33], results in a reduction in the extent of
Leishmania infection by promastigotes, probably by affect-
ing the binding of the parasite to the cell surface (Figure 2).
When hosts are examined for a longer period of time,adapted and modified from Ref. [32].
52 Opinion TRENDS in Parasitology Vol.23 No.2post-infection, a reduction in the number of the intracellular
amastigote form of the parasite is observed [32]. Impor-
tantly, the reduction in binding of L. donovani promasti-
gotes to cholesterol-depleted macrophages can be reversed
by replenishment of cholesterol (Figure 2), thereby reinfor-
cing the specific requirement of cholesterol in the infection
process [32]. As seen with Mycobacteria [18] and B. suis
[21], entry of serum-opsonized L. donovani promastigotes
into hostmacrophages seems to be unaffected by cholesterol
depletion or sequestration [32,33]. This points toward
the essential role of cholesterol in supporting entry of L.
donovani promastigotes via the non-opsonic pathway into
macrophages. More recently, cholesterol has been found to
be necessary for the entry of Leishmania chagasi into host
bone marrow macrophages through cholesterol-enriched
caveolar domains [34]. However, unlike L. donovani [32],
cholesterol depletion of bone marrow macrophages also
seems to inhibit the entry of opsonized L. chagasi [34].
Because studies with L. donovani [32,33] and L. chagasi
[34] were performed with virulent strains of the parasite,
these differences could therefore reflect a unique mode
of interaction between cholesterol and the cognate receptor
for opsonized L. donovani and L. chagasi on the host cell
surface.
Because amastigotes of Leishmania set up secondary
sites of infection in vivo, the role of cholesterol in their
entry into host tissues represents an important aspect in
Leishmania infection that needs to be explored. Never-
theless, the entry of promastigotes into host cells repre-
sents a crucial event in the establishment of primary
infection and cholesterol depletion of host macrophages
has been shown to effectively inhibit this process [32,34].
Consequently, cholesterol depletion has been found to
result in a concomitant reduction in the intracellular
amastigote form of the parasite in host macrophages
[32]. Whether such a reduction in the intracellular load
of amastigotes could serve to inhibit further infection in
vivo would require research trials at the preclinical stage.
Visceral leishmaniasis is characterized by defective cell-
mediated immunity [31]. Subsequent to their entry into
the host, Leishmania parasites prolong their survival by
subverting host immunity [35]. For example, L. donovani
infection results in a reduction in the ability of macro-
phages harboring the parasite to efficiently present para-
site antigens to T cells [36]. Defective antigen-presenting
ability of infected macrophages correlates with alterations
in the physical properties (such as dynamics of membrane-
embedded molecules) of macrophage cell membranes,
and has been proposed to be a mechanism employed by
the parasite to evade the host immune system [37].
Because cholesterol has a wide variety of effects on mem-
brane physical properties [2], a possible manner by which
Leishmania parasites achieve this could be by the uptake
of host cholesterol, as in the case of T. gondii (see above).
Restoration of these physical properties by an exogenous
supply of cholesterol to host cells leads to recovery in
antigen-presenting ability of Leishmania-infected macro-
phages [36]. These results indicate a role for cholesterol in
supporting Leishmania infection inside the host.
The requirement of cholesterol in supporting
host–pathogen interactions and pathogen survival withinwww.sciencedirect.comhost tissues seems to be fairly well established. However,
the question remains: by what mechanism does membrane
cholesterol influence these processes? The role of mem-
brane cholesterol in the function and cell surface organiza-
tion of integral membrane proteins has been extensively
investigated [14]. It is possible that the inhibition of patho-
gen interaction and infectivity could be a result of loss of
function of the several host receptors that pathogens use to
gain entry into cells, and/or a result of reorganization of
receptors that would otherwise have provided a favorable
platform for multivalent interactions with ligands on the
parasite cell surface.
Implications in leishmaniasis
The reduction in infection by cholesterol depletion might
lead to novel therapeutic strategies against leishmaniasis.
A major advantage of this approach lies in the fact that
development of drug resistance, an emerging problem
encountered in the treatment of leishmaniasis [38], is
virtually absent because the therapeutic focus is on the
host rather than the parasite. Based on the inhibitory
effects of cyclodextrins on Leishmania infection in vitro
[32–34], the feasibility of using cyclodextrins as a thera-
peutic strategy against leishmaniasis in vivo seems
encouraging. Earlier studies have shown that cyclodex-
trin-like molecules are important in treating unstable
atherosclerotic plaques as a result of their ability to remove
cholesterol from macrophage foam cells in vitro [39]. In
addition, cyclodextrins have been shown to cause hypolipi-
demic effects in genetically hypercholesterolimic rats when
fed orally [40]. Furthermore, intravenous administration
of cyclodextrins in normal rats has been shown to reduce
plasma cholesterol levels transiently in a dose-dependent
manner [41]. Whether reduction in the levels of plasma
cholesterol by cyclodextrin administration also manifests
in a reduction in levels of cell membrane cholesterol
remains to be determined, although this has been reported
to be true in the case of statin treatment [42].
As mentioned earlier, visceral leishmaniasis has
emerged as an important opportunistic infection among
people with HIV-1 infection [29]. Interestingly, cholesterol
has been reported to be essential for HIV-1 entry into host
cells [43,44], and topical application of cyclodextrins has
previously been shown to block the transmission of cell-
associated HIV-1 in mice [45]. The administration of com-
pounds that modulate membrane cholesterol levels can,
therefore, prove to be a powerful approach in tackling the
combined infection of leishmaniasis associated with HIV-1
infection. On a broader perspective, the requirement of
cholesterol in Leishmania infection forces re-evaluation of
the mechanism behind the effectiveness of current ther-
apeutic strategies to treat leishmaniasis. Among the pop-
ular clinically prescribed therapeutic drugs to treat
visceral leishmaniasis is amphotericin B [38], which is a
sterol-binding antibiotic [46]. Although amphotericin B is a
potent leishmanicidal agent [47], it is possible that its
effectiveness in vivo is based partly on its ability to seques-
ter cholesterol in the host membrane, thereby reducing
macrophage–parasite interactions, similar to what has
been observed for a related sterol-binding agent, nystatin,
in vitro [33].
Opinion TRENDS in Parasitology Vol.23 No.2 53Concluding remarks
In summary, the role of membrane cholesterol in diseases
caused by widely divergent intracellular pathogens is being
increasingly recognized. It is, therefore, timely to explore
compounds thatmodulate hostmembrane cholesterol levels
as a possible therapeutic strategy against such diseases.
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